🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Combretastatin A4

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Combretastatin A4, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

piperacillin
2 shared targets
Dicloxacillin
2 shared targets
effusol
2 shared targets
cefotaxime
2 shared targets
cefadroxil
2 shared targets
Thioctic
2 shared targets
Cephaloridine
2 shared targets
Dinoprost
4 shared targets
Cefamandole
2 shared targets
Cefoperazone
2 shared targets
Loading evidence profile...

This evidence profile for Combretastatin A4 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.